Financial Sense Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.3M | Buy |
673,029
+267,608
| +66% | +$4.49M | 2.66% | 9 |
|
|
2025
Q1 | $6.23M | Buy |
405,421
+157,421
| +63% | +$2.42M | 1.74% | 13 |
|
|
2024
Q4 | $5.47M | Sell |
248,000
-500
| -0.2% | -$11K | 1.81% | 8 |
|
|
2024
Q3 | $4.48M | Buy |
248,500
+4,000
| +2% | +$72.1K | 1.22% | 20 |
|
|
2024
Q2 | $3.97M | Sell |
244,500
-22,810
| -9% | -$371K | 1.21% | 18 |
|
|
2024
Q1 | $3.77M | Buy |
267,310
+17,310
| +7% | +$244K | 1.25% | 19 |
|
|
2023
Q4 | $2.61M | Buy |
250,000
+1,400
| +0.6% | +$14.6K | 0.97% | 29 |
|
|
2023
Q3 | $2.54M | Hold |
248,600
| – | – | 1.08% | 26 |
|
|
2023
Q2 | $1.87M | Sell |
248,600
-3,500
| -1% | -$26.4K | 0.79% | 39 |
|
|
2023
Q1 | $2.23M | Sell |
252,100
-4,000
| -2% | -$35.4K | 0.99% | 33 |
|
|
2022
Q4 | $2.34M | Sell |
256,100
-50,200
| -16% | -$458K | 0.96% | 27 |
|
|
2022
Q3 | $2.47M | Buy |
306,300
+49,000
| +19% | +$395K | 1.04% | 17 |
|
|
2022
Q2 | $1.94M | Buy |
+257,300
| New | +$1.94M | 0.71% | 33 |
|
|
2022
Q1 | – | Sell |
-207,500
| Closed | -$1.66M | – | 139 |
|
|
2021
Q4 | $1.66M | Sell |
207,500
-51,700
| -20% | -$414K | 0.57% | 39 |
|
|
2021
Q3 | $2.53M | Sell |
259,200
-1,965
| -0.8% | -$19.1K | 0.85% | 24 |
|
|
2021
Q2 | $2.59M | Buy |
261,165
+51,565
| +25% | +$511K | 0.81% | 26 |
|
|
2021
Q1 | $2.42M | Buy |
209,600
+11,000
| +6% | +$127K | 0.81% | 28 |
|
|
2020
Q4 | $1.92M | Sell |
198,600
-3,200
| -2% | -$30.9K | 0.69% | 32 |
|
|
2020
Q3 | $1.82M | Sell |
201,800
-48,943
| -20% | -$441K | 0.72% | 27 |
|
|
2020
Q2 | $3.09M | Sell |
250,743
-3,507
| -1% | -$43.2K | 1.1% | 17 |
|
|
2020
Q1 | $2.28M | Buy |
254,250
+49,450
| +24% | +$444K | 1.03% | 22 |
|
|
2019
Q4 | $2.01M | Buy |
204,800
+68,800
| +51% | +$674K | 0.74% | 28 |
|
|
2019
Q3 | $936K | Sell |
136,000
-8,500
| -6% | -$58.5K | 0.45% | 31 |
|
|
2019
Q2 | $1.33M | Sell |
144,500
-4,050
| -3% | -$37.4K | 0.59% | 25 |
|
|
2019
Q1 | $2.33M | Buy |
148,550
+38,050
| +34% | +$597K | 1.03% | 19 |
|
|
2018
Q4 | $1.7M | Buy |
110,500
+8,275
| +8% | +$128K | 1.08% | 13 |
|
|
2018
Q3 | $2.2M | Buy |
102,225
+5,250
| +5% | +$113K | 0.93% | 20 |
|
|
2018
Q2 | $2.36M | Buy |
96,975
+24,235
| +33% | +$589K | 1.64% | 15 |
|
|
2018
Q1 | $1.24M | Buy |
72,740
+31,840
| +78% | +$544K | 0.6% | 29 |
|
|
2017
Q4 | $775K | Buy |
+40,900
| New | +$775K | 0.36% | 36 |
|
|
2017
Q3 | – | Sell |
-6,009
| Closed | -$200K | – | 101 |
|
|
2017
Q2 | $200K | Buy |
+6,009
| New | +$200K | 0.1% | 87 |
|